Implementing a Cold Chain System Ensuring Cost Effectiveness and Reducing Unused Dispensed Chemotherapy Sue Hull Helen Wilkinson.

Slides:



Advertisements
Similar presentations
IHE Pharmacy profiles Hospital Medication Workflow status – July 2010.
Advertisements

Common/shared responsibilities between jobs.
C Commissioner Perspective How Quality Neonatal Clinical Indicators may relate to CQINs & QIPPs Ruth Moore Network Manager/Lead Nurse SSBC Newborn Network.
New Drug Capacity Calculator Instruction Manual An Excel-based tool for estimating the resource required to deliver newly approved chemotherapy drugs.
A New Way to Look at the Business of Healthcare Nancy Nahlik Missouri Baptist Medical Center BJC HealthCare March, 2014.
Taxanes for Ovarian Cancer: Progress Report Rosemary Tate Information Projects Team December 2000.
{ ADVERSE DRUG REACTIONS To ensure patient, family/caregiver and home health personnel are instructed to identify adverse reactions to medications and.
Development of Clinical Pharmacy Standards in Oncology
Hospital Information System (HIS) Stakeholder Consultation
Hospital Pharmacy Part-2
Good Clinical Practices Regulatory Guidelines for the Conduct of Clinical research Introduction to Research Pharmacy Services Javier Palacios, R.Ph. Sponsored.
St John’s Community Hospital Administration of IV Antibiotics Administration of Intravenous Antibiotics in St. John’s Community Hospital Melissa Kelly.
© 2005 Medixine Oy Piloting a Multimodal Medication Management System Tapio Jokinen, M.D., CEO Medixine Ltd
Improving the oncology patient’s journey within a Clinical Research Facility – using the National Chemotherapy Advisory Group (2009) Chemotherapy Pathway.
Improving the Quality and safety of care for Patients Transferred by Ambulance to Emergency Departments. Ambulance Patient Handover Protocol Ms Fiona Brady.
NECN S/C Herceptin Reactions October 2014 Wendy Anderson Macmillan Nurse Consultant Chemotherapy STNHSFT Melanie Robertson Nurse Consultant Oncology CHS.
Investigator Meeting January 2010 Protocol Review and Refresher.
Medication History: Keeping our patients safe. How do we get all of the correct details?
Introducing Quality Management in District Hospitals in Tanga Region First Experiences from Korogwe District Hospital.
Engaging the C-suite to Advance Pharmacy Practice Providing quality patient care through progressive pharmacy practice Evaluation of Unit-based Pharmacy.
The West Midlands Children and Young People’s Palliative Care Toolkit Lynette Thacker Clinical Nurse Specialist Paediatric Palliative Care ABMU Health.
Cold Chain Audit in compliance to NSQHS Std Yang Liu Stephen Lim Pam Allsop Pharmacy Department.
How to Find Your Way Around… SEPT - MANDATORY TRAINING 1. You can play the PowerPoint, and find the Test here EXAMPLE COURSE.
Can we afford to waste medicines? - update on possible national strategies Bhulesh Vadher Clinical Director of Pharmacy and Medicines Management, Oxford.
By J.Thitiri KEMRI-Wellcome Trust Research Programme Kilifi, Kenya PHARMACY AND PRODUCT ACCOUNTABILITY Version: 14-Nov-2009.
New Zealand – Can we live up to the ‘clean-green’ image? Dr Rhiannon Braund School of Pharmacy University of Otago New Zealand.
Management of IMP in Pharmacy Peter Fox STAKT Investigator Meeting Research & Development Pharmacy Services.
The Perfect Storm – are we eQIPP’d to survive it? Peter Rowe, National QIPP Lead – Medicines Use and Procurement Rowe Creative Limited ©
Pharmacy Administrator: Manager / Adminstrator for Pharmacies Research Leader for: oUoUniversities oHoHealth Insurance oPoPharmaceutical Companies.
A Dual View of Midwifery IT 12 th June 2012 Patricia Reilly IM&T Systems Support, Training and Development Manager.
Analysis of Patient Experience of Cancer Care Pathway within Merseyside & Cheshire Produced by Merseyside and Cheshire Cancer Network Presented: November.
Achieving safety and quality in MCCN chemotherapy services.
ASPECTS AFFECTING THE HOSPITAL OPERATION Financial Financial Operational Operational Administrative Administrative Clinical Clinical Safety Safety.
Theme 2: Hospital design to reduce adverse events CEO, Jane Kraglund Odense University Hospital.
Nicole Sutherlin Brianna Mays Eliza Guthorn John McDonough.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
Abstract Impact of the Essential Drugs Programme at the Primary Health Care Level in South Africa Hela M, Zeeman H, Department of Health South Africa;
St John Project Transport to the Medical Home 20,000 Days Campaign Learning Session March 2013 Project Manager: Jo Goodfellow.
Community Oncology Conference Ricky Newton, CPA Director of Financial Services and Operations and Treasurer April 24, 2015.
Dr. Colin Gilhooley.  Introduce myself  Background of Jinja Hospital  Triage  Emergency Care.
The Ministry of Health and Social Development of the Republic of Kazakhstan Republican Center for Health Development November 2015 Development of a network.
Network Patient Satisfaction Survey Gloria Payne, Patient & Carer Involvement Facilitator Ian Connolly, Performance Improvement Manager Lead Nurse Open.
Agenda BupaPrivate and Confidential Implementing a training and accreditation scheme for TTA pre-pack dispensing R Betmouni, N Gillani Pharmacy Department,
C McCaughey, D McKelvey, J Stewart, C Mallon, P Scullin
How the Clinical Effectiveness Team can help you to audit your Prescribing Practice Jude Scott Clinical Governance & Risk Management Unit Clinical Effectiveness.
Pharmacy Technician led chemotherapy education and toxicity assessment service: Oral Vinorelbine Sarah Goman Susan Edwards Carys Weale Bethan Tranter.
Educational solutions for the NHS pharmacy workforce Medicines Optimisation: Helping patients to make the most of medicines Sue Carter Regional Tutor
GB.DRO f, date of preparation: January 2010 Dartford and Gravesham NHS Trust Pharmacy Services in Hospital.
We’re counting the benefits of EPR Find out at: epr.this.nhs.uk We’re counting the benefits of EPR Find out at: epr.this.nhs.uk The introduction of EPR.
KENYATTA NATIONAL HOSPITAL. PROMOTING RATIONAL USE OF ANTI-RETROVIRALS (ARV) AT KENYATTA NATIONAL HOSPITAL (KNH) IN KENYA BY OGILE ELIZABETH BPharm Pg.
Mariesa Human René Grobler Netcare Milpark Hospital Reduction of Blood Product Wastage at a Level I Trauma Centre.
RCR Bladder Cancer Radiotherapy Audit 2016
Title of the Change Project
Network Audit on Virology Testing prior to R-Chemotherapy in patients with newly diagnosed DLBCL January to June 2016 Presented by Karan Wadhera.
Title of the Change Project
Daniel Phillips Antimicrobial Pharmacist
IAEA E-learning Program
Gill Butler NW Pharmacist Trainers Steering Group
Reducing Omitted Doses through Audit
Electronic Repeat Dispensing (eRD)
New Drug Capacity Calculator
The BAHNO Head & Neck Cancer Surveillance Audit 2018
Bringing Pharmaceutical Care to the Child’s Bedside
Survivorship Pathway Template
Advantages of Using Computers at Patient’s Bedsides in Hospitals
Chemotherapy Services in England: Ensuring quality and safety
Reducing Omitted Doses through Audit
Community Dispensing of Oral Medication for Prostate Cancer Patients
Collaborative Learning Workshops to Optimize Integration of Cancer
Hospital pharmacy.
Presentation transcript:

Implementing a Cold Chain System Ensuring Cost Effectiveness and Reducing Unused Dispensed Chemotherapy Sue Hull Helen Wilkinson

Introduction and Background Clatterbridge Centre for Oncology (CCO) treats patients within the Merseyside and Cheshire network Region. CCO covers a number of clinics both in-house and at Network Hospitals. The Pharmacy Department supplies Systemic Anti- Cancer Treatment to these clinics.

Chemotherapy is prepared in advance and taken to the clinics by CCO Nursing Staff where patients are then seen by CCO Consultants. A review of Chemotherapy Services which resulted in repatriation of patients to network clinics, showed an increased use of High Cost Drugs being administered outside of CCO In order to allow patients to be treated closer to home and at the same time minimise any unused chemotherapy a system needed to be put into place to enable reuse of returned chemotherapy.

Implementation To ensure a minimal wastage of chemotherapy drugs, implementation of a Cold Chain System was introduced. Nursing staff were brought on board with the Cold Chain Process. Pharmacy provided fridges to all clinics, these were monitored and results recorded over a period of time to ensure validation.

Validated boxes were sourced to ensure controlled temperature during transport of cold chain chemotherapy. Temperature loggers were also sourced for inclusion in boxes to record temperatures throughout transportation and clinic time. The loggers were to be returned to CCO at the end of the clinic and all data downloaded and recorded.

Specific network clinics were then chosen to be piloted. Any returned chemotherapy was documented to enable us to calculate any cost savings that could be made by reuse of the drugs once the process had been validated. Min TempMax tempMean Kinetic TempComments 3.6˚C 8.4˚C5.9˚CSee file 3.5˚C7˚C4.9˚CAll temps within limits 5.5˚C8.2˚C6.4˚CSee file 4.2˚C7.3˚C5.5˚CAll temps within limits 4.3˚C9.2˚C6.1˚C All temps within limits collection at end of recording) 4.72˚C9.77˚C6.71˚CAll clinic temps within limits (see file) 5.0˚C9.6˚C6.4˚C All temps within limits collection at end of recording) 4.5˚C7.6˚C6.0˚CAll temps within limits See File All temps within limits collection at end of recording) 4.1˚C7.0˚C5.9˚CAll temps within limits

Results Cold chain system implemented at pilot clinics, and a reduction of unused chemotherapy obtained producing cost savings.

Conclusion Further network clinics were established after the pilot scheme proved sustainable, efficient and cost effective. This is now a permanent working practice within the CCO Pharmacy Dept clinics